Casp9 Cancer Research Results

Casp9, Caspase-9: Click to Expand ⟱
Source:
Type:
Caspase-9 is the apoptotic initiator protease of the intrinsic or mitochondrial apoptotic pathway, which is activated at multi-protein activation platforms.
Caspases are divided into two groups: the initiator caspases (caspase-2, -8, -9 and -10), which are the first to be activated in response to a signal, and the executioner caspases (caspase-3, -6, and -7) that carry out the demolition phase of apoptosis.
Caspase-9:
Role: Initiator caspase in the intrinsic apoptotic pathway.
Cancers: Frequently studied in leukemia and solid tumors.
Prognosis: Reduced expression is often linked to chemoresistance and poor prognosis.


Scientific Papers found: Click to Expand⟱
4486- Se,  Chit,    Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis
- in-vitro, Liver, HepG2
Apoptosis↑, TumCCA↑, MMP↓, Bcl-2↓, BAX↑, cl‑Casp9↑, cl‑Casp3↑, Risk↓, *BioAv↑, *toxicity↑, TumCG↓, AntiTum↑, ROS↑, Cyt‑c↑, Fas↑, FasL↑, FADD↑,
4484- Se,  Chit,  PEG,    Anti-cancer potential of selenium-chitosan-polyethylene glycol-carvacrol nanocomposites in multiple myeloma U266 cells
- in-vitro, Melanoma, U266
tumCV↓, selectivity↑, ROS↑, MMP↓, Apoptosis↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓,
4471- SeNPs,    Green synthesis of selenium nanoparticles with extract of hawthorn fruit induced HepG2 cells apoptosis
- in-vitro, Liver, HepG2
eff↑, ROS↑, MMP↓, Casp9↑, Bcl-2↓, selectivity↑, Apoptosis↑,
4469- SeNPs,    Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential
- Review, Var, NA
antiOx↑, selectivity↑, eff↑, AntiCan↑, Apoptosis↑, ROS↑, MMP↓, Casp3↑, Casp9↑, AntiTum↑, TumCG↓, TumMeta↓, angioG↓, Cyt‑c↑, DNAdam↑, RadioS↑, BBB↑, *toxicity↓, ChemoSen↑,
4453- SeNPs,    Selenium Nanoparticles: Green Synthesis and Biomedical Application
- Review, Var, NA
*toxicity↓, *Bacteria↓, ROS↑, MMP↓, ER Stress↑, P53↑, Apoptosis↑, Casp9↑, DNAdam↑, TumCCA↑, eff↑, Catalase↓, SOD↓, GSH↓, selectivity↓, selectivity↑, PCNA↓, eff↑, *ALAT↓, *AST↓, *ALP↓, *creat↓, *Inflam↓, *toxicity↓, selectivity↑,
3656- SFN,    Chronic diseases, inflammation, and spices: how are they linked?
- Review, AD, NA
*AntiCan↑, *cardioP↑, *NRF2↑, *Inflam↓, *NF-kB↓, *STAT3↓, *ERK↓, *MAPK↓, AP-1↑, Bcl-2↓, Casp3↑, Casp9↑,
1459- SFN,  AF,    Auranofin Enhances Sulforaphane-Mediated Apoptosis in Hepatocellular Carcinoma Hep3B Cells through Inactivation of the PI3K/Akt Signaling Pathway
- in-vitro, Liver, Hep3B - in-vitro, Liver, HepG2
eff↑, TumCCA↑, Apoptosis↑, MMP↓, BAX↑, cl‑PARP↑, Casp3↑, Casp8↑, Casp9↑, ROS↑, eff↓, PI3K↓, Akt↓, TrxR↓, BAX↑, Bcl-2∅,
1469- SFN,    Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis
- in-vitro, Pca, PC3 - in-vitro, Pca, LNCaP - in-vivo, Pca, NA
Synergy↑, ROS↑, MMP↓, Casp3↑, Casp9↑, DR4↑, DR5↑, BAX↑, Bak↑, BIM↑, NOXA↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, eff↓, TumCG↓, TumCP↓, eff↑, NF-kB↓, PI3K↓, Akt↓, MEK↓, ERK↓, angioG↓, FOXO3↑,
1463- SFN,    Sulforaphane induces reactive oxygen species-mediated mitotic arrest and subsequent apoptosis in human bladder cancer 5637 cells
- in-vitro, Bladder, 5637
tumCV↓, CycB/CCNB1↑, p‑CDK1↑, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, ROS↑, eff↓,
1458- SFN,    Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma
- Review, Bladder, NA
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2/PTGS2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,
1474- SFN,    Sulforaphane induces p53‑deficient SW480 cell apoptosis via the ROS‑MAPK signaling pathway
- in-vitro, Colon, SW480
TumCG↓, Apoptosis↑, MMP↓, Bax:Bcl2↑, Casp3↑, Casp7↑, Casp9↑, ROS↑, e-ERK↑, p38↑, P53∅, eff↓, ChemoSen↑,
1508- SFN,    Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment
- Review, Var, NA
*BioAv↑, HDAC↓, TumCCA↓, eff↓, Wnt↓, β-catenin/ZEB1↓, Casp12?, Bcl-2↓, cl‑PARP↑, Bax:Bcl2↑, IAP1↓, Casp3↑, Casp9↑, Telomerase↓, hTERT/TERT↓, ROS?, DNMTs↓, angioG↓, VEGF↓, Hif1a↓, cMYB↓, MMP1↓, MMP2↓, MMP9↓, ERK↑, E-cadherin↑, CD44↓, MMP2↓, Synergy↑, IL2↑, IFN-γ↑, IL1β↓, IL6↓, TNF-α↓, NF-kB↓, ERK↓, NRF2↑, RadioS↑, ChemoSideEff↓,
1482- SFN,    Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway
- in-vitro, Bladder, T24/HTB-9
tumCV↓, Apoptosis↑, Cyt‑c↑, Bax:Bcl2↑, Casp9↑, Casp3↑, Casp8∅, cl‑PARP↑, ROS↑, MMP↓, eff↓, ER Stress↑, p‑NRF2↑, HO-1↑,
1722- SFN,    Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems
- Review, Var, NA
TumCCA↑, CYP1A1↓, CYP3A4↓, Cyt‑c↑, Casp9↑, Apoptosis↑, ROS↑, MAPK↑, P53↑, BAX↑, ChemoSen↑, HDAC↓, GSH↓, HO-1↑,
1735- SFN,    Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane
- in-vitro, GBM, T98G - in-vitro, GBM, U87MG
Apoptosis↑, Ca+2↑, Bax:Bcl2↑, cal2↑, Casp12↑, Casp9↑, Cyt‑c↑,
1726- SFN,    Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential
- Review, Var, NA
Dose↝, eff↝, IL1β↓, IL6↓, IL12↓, TNF-α↓, COX2/PTGS2↓, CXCR4↓, MPO↓, HSP70/HSPA5↓, HSP90↓, VCAM-1↓, IKKα↓, NF-kB↓, HO-1↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, Cyt‑c↑, Diablo↑, CHOP/DDIT3↑, survivin↓, XIAP↓, p38↑, Fas↑, PUMA↑, VEGF↓, Hif1a↓, Twist↓, Zeb1↓, Vim↓, MMP2↓, MMP9↓, E-cadherin↑, N-cadherin↓, Snail↓, CD44↓, cycD1/CCND1↓, cycA1/CCNA1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK4↓, CDK6↓, p50↓, P53↑, P21↑, GSH↑, SOD↑, GSTs↑, mTOR↓, Akt↓, PI3K↓, β-catenin/ZEB1↓, IGF-1↓, cMyc↓, CSCs↓,
1730- SFN,    Sulforaphane: An emergent anti-cancer stem cell agent
- Review, Var, NA
BioAv↓, BioAv↑, GSTA1↑, P450↓, TumCCA↑, HDAC↓, P21↑, p27/CDKN1B↑, DNMT1↓, DNMT3A↓, cycD1/CCND1↑, DNAdam↑, BAX↑, Cyt‑c↑, Apoptosis↑, ROS↑, AIF↑, CDK1↑, Casp3↑, Casp8↑, Casp9↑, NRF2↑, NF-kB↓, TNF-α↓, IL1β↓, CSCs↓, CD133↓, CD44↓, ALDH↓, Nanog↓, OCT4↓, hTERT/TERT↓, MMP2↓, EMT↓, ALDH1A1↓, Wnt↓, NOTCH↓, ChemoSen↑, *Ki-67↓, *HDAC3↓, *HDAC↓,
3305- SIL,    Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vivo, NA, NA
TumCP↓, tumCV↓, BAX↑, cl‑PARP↑, Casp9↑, p‑JNK↑, Bcl-2↓, p‑p38↓, p‑ERK↓, *toxicity∅, Dose↝, *hepatoP↑, Inflam↓, AntiCan↑,
3301- SIL,    Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid
- Review, Var, NA
Inflam↓, TumCCA↑, Apoptosis↓, TumMeta↓, TumCG↓, angioG↓, chemoP↑, radioP↑, p‑ERK↓, p‑p38↓, p‑JNK↓, P53↑, Bcl-2↓, Bcl-xL↓, TGF-β↓, MMP2↓, MMP9↓, E-cadherin↑, Wnt↓, Vim↓, VEGF↓, IL6↓, STAT3↓, *ROS↓, IL1β↓, PGE2↓, CDK1↓, CycB/CCNB1↓, survivin↓, Mcl-1↓, Casp3↑, Casp9↑, cMyc↓, COX2/PTGS2↓, Hif1a↓, CXCR4↓, CSCs↓, EMT↓, N-cadherin↓, PCNA↓, cycD1/CCND1↓, ROS↑, Synergy↑, Synergy↑, Synergy↑, HER2/EBBR2↓,
3293- SIL,    Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
- Review, Var, NA
hepatoP↑, TumMeta↓, Inflam↓, chemoP↑, radioP↑, Half-Life↝, *GSTs↑, p‑JNK↑, BAX↑, p‑p38↑, cl‑PARP↑, Bcl-2↓, p‑ERK↓, TumVol↓, Synergy↑, TumCCA↑, STAT3↓, Mcl-1↓, survivin↓, Bcl-xL↓, Casp3↑, Casp9↑, eff↑, CXCR4↓, Dose↝,
3289- SIL,    Silymarin: a promising modulator of apoptosis and survival signaling in cancer
- Review, Var, NA
*BioAv↝, *BioAv↓, Fas↑, FasL↑, FADD↑, pro‑Casp8↑, Apoptosis↑, DR5↑, Bcl-2↑, BAX↑, Casp3↑, PI3K↓, FOXM1↓, p‑mTOR↓, p‑P70S6K↓, Hif1a↓, Akt↑, angioG↓, STAT3↓, NF-kB↓, lipid-P↓, Synergy↑, CDK1↓, survivin↓, CycB/CCNB1↓, Mcl-1↓, Casp9↑, AP-1↓, BioAv↑,
3325- SIL,    Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injury
- in-vivo, Nor, NA
*Inflam↓, *ROS↓, *Casp3↑, *Casp9↑, *Hif1a↓, *iNOS↓, *SOD↑, *MDA↓,
3648- SIL,    Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
- Review, Var, NA
*antiOx↑, *Inflam↓, *lipid-P↓, *necrosis↓, *hepatoP↑, *IL1↓, *IL6↓, *TNF-α↓, *IFN-γ↓, MAPK↓, Apoptosis↑, Cyt‑c↑, Casp3↑, Casp9↑, *PPARγ↑, *GLUT4↑, *HSPs↓, *HSP27↑, *Trx↑, *SIRT1↑, *ALAT↓, *GSH↑, *lipid-P↓, *TNF-α↓, TumCG↓, P21↑, CDK4↑,
1140- SIL,    Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
- in-vitro, PC, AsPC-1 - in-vivo, PC, NA - in-vitro, PC, MIA PaCa-2 - in-vitro, PC, PANC1 - in-vitro, PC, Bxpc-3
TumCG↓, Glycolysis↓, cMyc↓, STAT3↓, TumCP↓, Weight∅, Strength↑, DNAdam↑, Casp3↑, Casp9↑, GLUT1↓, HK2↓, LDHA↓, GlucoseCon↓, lactateProd↓, PPP↓, Ki-67↓, p‑STAT3↓, cachexia↓,
978- SIL,    A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment
- Review, Var, NA
PI3K↓, Akt↓, NF-kB↓, Wnt/(β-catenin)↓, MAPK↓, TumCP↓, TumCCA↑, Apoptosis↑, p‑EGFR↓, JAK2↓, STAT5↓, cycD1/CCND1↓, hTERT/TERT↓, AP-1↓, MMP9↓, miR-21↓, miR-155↓, Casp9↑, BID↑, ERK↓, Akt2↓, DNMT1↓, P53↑, survivin↓, Casp3↑, ROS↑,
2231- SK,    Shikonin Exerts Cytotoxic Effects in Human Colon Cancers by Inducing Apoptotic Cell Death via the Endoplasmic Reticulum and Mitochondria-Mediated Pathways
- in-vitro, CRC, SNU-407
Apoptosis↑, ER Stress↑, PERK↑, eIF2α↑, CHOP/DDIT3↑, mt-Ca+2↑, MMP↓, Bcl-2↓, Casp3↑, Casp9↑, ERK↑, JNK↑, p38↓,
2197- SK,    Shikonin derivatives for cancer prevention and therapy
- Review, Var, NA
ROS↑, Ca+2↑, BAX↑, Bcl-2↓, MMP9↓, NF-kB↓, PKM2↓, Hif1a↓, NRF2↓, P53↑, DNMT1↓, MDR1↓, COX2/PTGS2↓, VEGF↓, EMT↓, MMP7↓, MMP13↓, uPA↓, RIP1↑, RIP3↑, Casp3↑, Casp7↑, Casp9↑, P21↓, DFF45↓, TRAIL↑, PTEN↑, mTOR↓, AR↓, FAK↓, Src↓, Myc↓, RadioS↑,
2228- SK,    Shikonin induced Apoptosis Mediated by Endoplasmic Reticulum Stress in Colorectal Cancer Cells
- in-vitro, CRC, HCT116 - in-vitro, CRC, HCT15 - in-vivo, NA, NA
Apoptosis↑, Bcl-2↓, Casp3↑, Casp9↑, cl‑PARP↑, GRP78/BiP↑, PERK↑, eIF2α↑, ATF4↑, CHOP/DDIT3↑, JNK↑, eff↓, ER Stress↑, ROS↑, TumCG↓,
3044- SK,    Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway
- in-vitro, Lung, H1299 - in-vitro, Lung, H460
TumCP↓, survivin↓, TumCCA↓, CDK2↓, CDK4↓, XIAP↓, Casp3↑, Casp9↑, cycD1/CCND1↓, cycE/CCNE↓,
2007- SK,    Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells
- in-vitro, lymphoma, U937 - in-vitro, BC, MCF7 - in-vitro, BC, SkBr3 - in-vitro, CRC, HCT116 - in-vitro, OS, U2OS - NA, Nor, RPE-1
tumCV↓, selectivity↑, Dose↝, other↑, MMP↓, ROS↑, DNAdam↑, Ca+2↑, Casp9↑, Cyt‑c↑, *toxicity↓,
9033- SP,    Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential
- Review, Var, NA
Apoptosis↑, TumCCA↑, angioG↓, VEGF↓, VEGFR1↓, EMT↓, Ingr↝, Imm↑, pol-M1↑, Th1 response↑, Th17↑, chemoP↑, BioAv↓, Synergy?, Ingr↝, Ingr↝, Ingr↝, ROS⇅, ROS↑, mtDam↑, DNAdam↑, SOD↓, Bcl-2↓, Casp3↑, MDA↓, Catalase↑, ROS↓, MOMP↑, Cyt‑c↑, Casp9↑, CellShr↑, ChrCon↑, Dose↝, TNFR 1↑, FADD↑, TRADD↑, Beclin-1/ATG6↑, PI3K↓, Akt↓, mTOR↓, TumAuto↑, TumCMig↓, TumCI↓, Vim↓, Fibronectin↓, COL1↓, MMP2↓, MMP9↓, COX2/PTGS2↓, MCP1/CCL2↓, ICAM-1↓, VCAM-1↓, Snail↓, Slug↓, Zeb1↓, Twist↓, E-cadherin↑, chemoP↑, *hepatoP↑, *lipid-P↓, *Casp3↓, *BAX↓, RenoP↑, *creat↓, *Urea↓, *SOD↑, *Catalase↑, *neuroP↑, *cognitive↑, *ROS↓, *NeuroI↓, *memory↑, *BDNF↑, *CREB↑, *toxicity↓, *toxicity↝, *BioAv↓, *BioAv↓, *Half-Life↝,
5111- SSE,    Sodium selenite induces apoptosis via ROS-mediated NF-κB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells
- in-vitro, BC, 4T1
ROS↑, NF-kB↓, p65↓, mtDam↑, Casp9↑, Casp3↑, Apoptosis↑, eff↓,
5105- SSE,    Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells
- in-vitro, Pca, LNCaP
TumCD↑, Apoptosis↑, ROS↑, eff↓, MMP↓, Cyt‑c↑, Casp3↑, Casp9↑, ER Stress↑, TumAuto↑, necrosis↑, chemoPv↑,
6431- T4O,    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo
- vitro+vivo, NSCLC, A549
TumCCA↑, Casp3↑, Casp9↑, cl‑PARP↑, MMP↓, Bax:Bcl2↑, XIAP↓, survivin↓, Dose↝, Apoptosis↑, tumCV↓, Cyt‑c↑, eff↑, necrosis↑,
5331- TFdiG,    Anti-Cancer Properties of Theaflavins
- Review, Var, NA
AntiCan↑, TumCP↓, TumCMig↓, Apoptosis↑, cl‑PARP↑, cl‑Casp3↑, cl‑Casp7↑, cl‑Casp8↑, cl‑Casp9↑, BAX↑, Bcl-2↓, p‑Akt↓, p‑mTOR↓, PI3K↓, cMyc↓, P53↑, ROS↑, NF-kB↓, MMP9↓, MMP2↓, TumVol↓, PSA↓, TumCCA↑, VEGF↓, Hif1a↓, CDK2↓, CDK4↓, GSH↓, Dose↑, BioAv↓, BioAv↓, BioAv↑,
5332- TFdiG,    Theaflavin-3,3′-digallate triggers apoptosis in osteosarcoma cells via the caspase pathway
- vitro+vivo, OS, 143B - in-vitro, OS, U2OS
tumCV↓, cl‑Casp3↑, cl‑Casp9↑, p‑γH2AX↑, BAX↑, Bak↑, Cyt‑c↑, Mcl-1↓, survivin↓, TumVol↓, Wnt↓, β-catenin/ZEB1↓, Dose↝, ROS↑, eff↓, TumW↓, Ki-67↓,
5334- TFdiG,    Theaflavin inhibits the malignant phenotype of human anaplastic thyroid cancer 8305C cells by regulating lipid metabolism via PI3K/AKT signaling
- in-vitro, Thyroid, 8505C
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Casp3↑, Casp8↑, Casp9↑, survivin↓, SREBP1/SREBF1↓, toxicity↑,
5221- TQ,    Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells
- in-vitro, AML, HL-60
chemoPv↑, Apoptosis↑, MMP↓, Casp8↑, Casp9↑, Bax:Bcl2↑, Cyt‑c↑,
2112- TQ,    Crude flavonoid extract of the medicinal herb Nigella sativa inhibits proliferation and induces apoptosis in breastcancer cells
- in-vitro, BC, MCF7
Apoptosis↑, DNAdam↑, ROS↑, GSH↓, MMP↓, Casp3↑, Casp7↑, Casp9↑, Bax:Bcl2↑, P53↑, P21↑, cycD1/CCND1↓, GSSG↑, GSH/GSSG↓,
2120- TQ,    Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3
- in-vitro, Melanoma, A431
ROS↑, Apoptosis↑, P53↑, BAX↑, MDM2↓, Bcl-2↓, Bcl-xL↓, Casp9↑, Casp7↑, Casp3↑, STAT3↓, cycD1/CCND1↓, survivin↓, eff↓,
2123- TQ,    Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma
- in-vitro, lymphoma, PEL
Akt↓, ROS↑, BAX↓, MMP↓, Cyt‑c↑, Synergy↑, Casp9↑, Casp3↑, cl‑PARP↑, DR5↑,
2085- TQ,    Anticancer Activities of Nigella Sativa (Black Cumin)
- Review, Var, NA
MMP↓, Casp3↑, Casp8↑, Casp9↓, cl‑PARP↑, Cyt‑c↑, Bax:Bcl2↑, NF-kB↓, IAP1↓, IAP2/BIRC3↓, XIAP↓, Bcl-xL↓, survivin↓, cJun↑, p38↑, Akt↑, chemoP↑, *radioP↑, *antiAll↑,
2095- TQ,    Review on the Potential Therapeutic Roles of Nigella sativa in the Treatment of Patients with Cancer: Involvement of Apoptosis
- Review, Var, NA
TumCCA↑, Apoptosis↑, ROS↑, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, cl‑PARP↑, P53↑, P21↑, cMyc↓, hTERT/TERT↓, cycD1/CCND1↓, CDK4↓, NF-kB↓, IAP1↓, IAP2/BIRC3↓, XIAP↓, Bcl-xL↓, survivin↓, COX2/PTGS2↓, MMP9↓, VEGF↓, ChemoSen↑,
2097- TQ,    Crude extract of Nigella sativa inhibits proliferation and induces apoptosis in human cervical carcinoma HeLa cells
- in-vitro, Cerv, HeLa
Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8↑, cl‑PARP↑, cMyc↓, hTERT/TERT↓, cycD1/CCND1↓, CDK4↓, P53↑, P21↑, TumCP↓, Apoptosis↓, selectivity↑,
2083- TQ,    Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro
- in-vitro, GC, HGC27 - in-vitro, GC, BGC-823 - in-vitro, GC, SGC-7901 - in-vivo, NA, NA
p‑STAT3↓, JAK2↓, c-Src↓, Bcl-2↓, cycD1/CCND1↓, survivin↓, VEGF↓, Casp3?, Casp7?, Casp9?, *toxicity∅, TumVol↓,
2110- TQ,    Nigella sativa seed oil suppresses cell proliferation and induces ROS dependent mitochondrial apoptosis through p53 pathway in hepatocellular carcinoma cells
- in-vitro, HCC, HepG2 - in-vitro, BC, MCF7 - in-vitro, Lung, A549 - in-vitro, Nor, HEK293
P53↑, lipid-P↑, GSH↓, ROS↑, MMP↓, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, tumCV↓, selectivity↑,
8465- TQ,  docx,    Thymoquinone Potentiates Docetaxel-Induced Antitumor Activity with the Involvement of ROS and PI3K/AKT Pathway Modulation in Triple-Negative Breast Cancer Cells
- in-vitro, BC, NA
ChemoSen?, ROS↑, eff↓, Bcl-2↓, PI3K↓, AKT1↓, BAX↑, Casp9↑, PTEN↑,
3413- TQ,    Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase
- in-vitro, CRC, HCT116
tumCV↓, Apoptosis↓, BAX↑, Bcl-2↓, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, STAT3↓, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, EGFR↓, ROS↑,
3414- TQ,    Thymoquinone induces apoptosis through inhibition of JAK2/STAT3 signaling via production of ROS in human renal cancer Caki cells
- in-vitro, RCC, Caki-1
tumCV↓, Apoptosis↑, P53↑, BAX↑, Cyt‑c↑, cl‑Casp9↑, cl‑Casp3↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, p‑STAT3↓, p‑JAK2↓, STAT3↓, survivin↓, cycD1/CCND1↓, ROS↑, eff↓,
3397- TQ,    Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer
- Review, CRC, NA
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2/PTGS2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,

Showing Research Papers: 501 to 550 of 563
Prev Page 11 of 12 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 563

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA⇅, 1,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 2,   antiOx↑, 7,   antiOx⇅, 1,   ARE↓, 1,   Catalase↓, 14,   Catalase↑, 7,   Copper↑, 1,   Fenton↑, 2,   frataxin↑, 1,   GCLC↑, 1,   GCLM↓, 1,   GCLM↑, 1,   GPx↓, 5,   GPx↑, 3,   GPx4↓, 5,   GSH↓, 40,   GSH↑, 9,   GSH/GSSG↓, 4,   GSR↑, 3,   GSS↑, 1,   GSSG↓, 1,   GSSG↑, 1,   GSTs↓, 1,   GSTs↑, 3,   H2O2↓, 1,   H2O2↑, 8,   i-H2O2↑, 1,   HO-1↓, 7,   HO-1↑, 13,   HO-1↝, 1,   HO-2↓, 1,   Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 8,   lipid-P↑, 13,   lipid-P↝, 1,   MDA↓, 5,   MDA↑, 5,   MPO↓, 2,   NADPH/NADP+↓, 1,   NOX4↑, 1,   NQO1↓, 1,   NQO1↑, 2,   Nrf1↑, 1,   NRF2↓, 17,   NRF2↑, 23,   p‑NRF2↓, 1,   p‑NRF2↑, 1,   Prx↓, 1,   Prx4↑, 1,   PrxII↓, 1,   ROS?, 4,   ROS↓, 26,   ROS↑, 268,   ROS⇅, 10,   ROS↝, 2,   ROS∅, 1,   i-ROS↓, 1,   i-ROS↑, 5,   mt-ROS↑, 7,   SAM-e↝, 1,   SOD?, 1,   SOD↓, 15,   SOD↑, 8,   SOD2↓, 3,   SOD2↑, 2,   TBARS↑, 2,   Thiols↓, 1,   Trx↓, 1,   Trx1↑, 1,   ox-Trx1↑, 1,   TrxR↓, 6,   TrxR1↓, 3,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 2,   FTL↑, 1,   IronCh↑, 3,   NCOA4↑, 1,   STEAP3↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 2,   BCR↓, 1,   CDC2↓, 8,   CDC25↓, 18,   CDC25↑, 1,   p‑CDC25↑, 1,   compI↓, 2,   compIII↓, 1,   compIV↓, 1,   compV↓, 1,   EGF↓, 4,   ETC↓, 2,   ETC↝, 1,   Insulin↓, 2,   MCU↓, 1,   MFN2↓, 1,   MFN2↑, 1,   mitResp↓, 2,   MKK7↓, 1,   mtDam↑, 32,   OCR↓, 3,   OXPHOS↓, 1,   mt-OXPHOS↓, 1,   PDH↓, 1,   PINK1↑, 2,   SDH↓, 2,   SIRT3↓, 2,   SIRT3↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 6,   5LO↓, 2,   p‑ACC↑, 1,   ACLY↓, 2,   ACSL4↑, 1,   ACSL5↑, 2,   ALAT↓, 2,   ALAT↑, 1,   ALAT↝, 1,   ALDOA↓, 1,   AMP↑, 1,   AMPK↓, 1,   AMPK↑, 19,   AMPK↝, 1,   p‑AMPK↑, 2,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 14,   ATP↝, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   citrate↓, 1,   CPT1A↓, 1,   ECAR↝, 1,   ENO1↓, 2,   FASN↓, 2,   FASN↑, 2,   FBPase↑, 1,   GLS↓, 1,   glucoNG↑, 1,   glucose↓, 1,   GlucoseCon↓, 12,   GlutMet↓, 1,   Glycolysis↓, 24,   GSK‐3β↓, 10,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 5,   p‑GSK‐3β↑, 1,   Histones↑, 1,   HK1↓, 1,   HK2↓, 11,   lactateProd↓, 10,   lactateProd↑, 1,   LDHA↓, 6,   LDL↓, 1,   NAD↝, 1,   NADPH↓, 2,   NADPH↑, 2,   O-Glc↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 6,   PFK↓, 1,   PFK1↓, 2,   PFK2?, 1,   PFK2↓, 2,   PFKP↓, 1,   PGK1↓, 1,   PKM2↓, 4,   PKM2∅, 1,   PLA2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 1,   p‑S6↓, 1,   SAT1↑, 1,   SIRT1↓, 5,   SIRT1↑, 2,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA?, 1,   TCA↓, 3,   TCA↑, 1,   TS↓, 3,   Warburg↓, 3,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

14-3-3 proteins↓, 1,   AIF↑, 23,   APAF1↑, 19,   Apoptosis↓, 9,   Apoptosis↑, 293,   mt-Apoptosis↑, 4,   ASK1↑, 2,   BAD?, 1,   BAD↓, 4,   BAD↑, 21,   p‑BAD↓, 1,   Bak↓, 1,   Bak↑, 16,   BAX?, 1,   BAX↓, 2,   BAX↑, 235,   BAX⇅, 1,   BAX↝, 1,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 54,   Bcl-2↓, 232,   Bcl-2↑, 6,   Bcl-2↝, 1,   Bcl-2∅, 1,   cl‑Bcl-2↓, 1,   Bcl-xL↓, 56,   Bcl-xL↑, 2,   BID↓, 2,   BID↑, 17,   p‑BID↓, 1,   cl‑BID↑, 3,   BIM↑, 5,   BNIP3↑, 2,   BNIP3↝, 1,   BOK↑, 2,   Casp↑, 13,   Casp↝, 1,   Casp10↓, 1,   Casp10↑, 3,   Casp12?, 1,   Casp12↑, 10,   Casp12↝, 1,   cl‑Casp12↑, 1,   Casp2↑, 5,   Casp3?, 1,   Casp3↓, 7,   Casp3↑, 380,   Casp3↝, 1,   Casp3∅, 1,   cl‑Casp3↓, 1,   cl‑Casp3↑, 66,   cl‑Casp3⇅, 1,   proCasp3↓, 3,   proCasp3↑, 4,   pro‑Casp3↑, 1,   CASP4↑, 2,   Casp6↓, 1,   Casp6↑, 4,   Casp7?, 1,   Casp7↑, 41,   cl‑Casp7↑, 8,   Casp8↓, 3,   Casp8↑, 126,   Casp8↝, 1,   Casp8∅, 2,   cl‑Casp8↑, 18,   proCasp8↓, 2,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9?, 2,   Casp9↓, 4,   Casp9↑, 441,   Casp9↝, 1,   Casp9∅, 1,   p‑Casp9↑, 2,   cl‑Casp9↓, 2,   cl‑Casp9↑, 70,   proCasp9↓, 4,   proCasp9↑, 5,   pro‑Casp9↑, 1,   CellShr↑, 1,   cFLIP↓, 11,   Cyt‑c↓, 3,   Cyt‑c↑, 192,   Cyt‑c↝, 1,   Cyt‑c?, 1,   Diablo↑, 10,   DR5↑, 37,   Endon↑, 1,   FADD↑, 14,   Fas↓, 2,   Fas↑, 32,   FasL↓, 1,   FasL↑, 23,   Ferroptosis↑, 5,   cl‑GSDME↑, 1,   HEY1↓, 1,   IAP1↓, 15,   IAP2/BIRC3↓, 5,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 16,   Mcl-1↓, 41,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 11,   MDM2↑, 2,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↓, 1,   MOMP↑, 8,   NAIP↓, 2,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 7,   p38↓, 6,   p38↑, 30,   p‑p38↓, 4,   p‑p38↑, 6,   PUMA↑, 6,   PUMA↝, 1,   Pyro↑, 1,   RIP3↑, 3,   p‑RIP3↑, 1,   survivin↓, 66,   survivin↝, 1,   TNFR 1↑, 2,   TRAIL↑, 9,   TRAILR↑, 2,   TumCD↓, 1,   TumCD↑, 22,   XIAP↓, 36,   XIAP↑, 1,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt?, 1,   Akt↓, 122,   Akt↑, 8,   p‑Akt↓, 45,   AKT1↓, 6,   Akt2↓, 2,   AMPKα↑, 1,   BRAF↝, 1,   CaMKII ↓, 2,   CK2↓, 4,   cMET↓, 3,   p‑cMET↑, 1,   CREB2↓, 1,   cSrc↓, 3,   EF-1α↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 3,   ERK↓, 44,   ERK↑, 11,   p‑ERK↓, 17,   p‑ERK↑, 4,   p‑ERK⇅, 1,   e-ERK↑, 1,   FGFR1↓, 3,   FGFR2↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 14,   Hippo↑, 1,   HRAS↓, 2,   IGF-1R↓, 8,   IKKα↓, 5,   IKKα↑, 1,   p‑IKKα↓, 1,   IκB↑, 1,   p‑IκB↓, 3,   JAK↓, 3,   JAK1↓, 4,   JAK1↑, 1,   JAK2↓, 9,   p‑JAK2↓, 2,   JNK↓, 6,   JNK↑, 34,   p‑JNK↓, 5,   p‑JNK↑, 4,   cl‑JNK↑, 1,   LIMK1↓, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 34,   MAPK↑, 23,   MAPK↝, 2,   p‑MAPK↓, 1,   p‑MAPK↑, 1,   MEK↓, 6,   p‑MEK↓, 3,   p‑MEK↑, 1,   MKK4↓, 1,   mTOR↓, 59,   mTOR↑, 1,   mTOR↝, 2,   p‑mTOR↓, 16,   mTORC2↓, 3,   NRAS↓, 1,   p70S6↓, 2,   p70S6↑, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   P90RSK↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 1,   PI3K↓, 88,   PI3K↑, 2,   p‑PI3K↓, 8,   PI3K/Akt↓, 6,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↝, 1,   PIAS-3↑, 1,   PIK3CA↓, 1,   PKA↓, 2,   PKCδ↓, 8,   p‑PKCδ↓, 1,   cl‑PKCδ↑, 1,   PTEN↓, 2,   PTEN↑, 31,   PTEN↝, 1,   Raf↓, 8,   c-Raf↓, 1,   RAS↓, 8,   RAS↑, 1,   RIP1↑, 1,   S6K↓, 1,   p‑S6K↓, 1,   SHP1↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 5,   Src↓, 3,   c-Src↓, 1,   STAT↓, 2,   STAT3↓, 54,   STAT3↑, 2,   p‑STAT3↓, 15,   p‑STAT3↑, 2,   STAT5↓, 2,   STAT6↓, 1,   TK1↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 2,   ATF4↑, 12,   ATF4↝, 1,   ATFs↑, 1,   ChrMod↝, 1,   cJun↓, 5,   cJun↑, 4,   p‑cJun↑, 2,   cMyc↓, 33,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMTs↓, 5,   EZH2↓, 2,   FOXM1↓, 1,   FOXO↑, 2,   FOXO1↑, 4,   FOXO3↓, 3,   FOXO3↑, 6,   FOXO4↑, 1,   GATA3↑, 1,   H3↑, 2,   ac‑H3↑, 1,   H4↑, 2,   ac‑H4↑, 1,   HATs↓, 6,   HATs↑, 1,   HDAC↓, 16,   HDAC1↓, 4,   HDAC10↑, 1,   HDAC2↓, 2,   HDAC3↓, 4,   HDAC8↓, 2,   HES1↓, 1,   HMTs↓, 1,   miR-106b↓, 1,   miR-133a-3p↑, 1,   miR-155↓, 3,   miR-17↓, 1,   miR-195↑, 1,   miR-21↓, 6,   miR-21↑, 1,   miR-221↓, 1,   miR-25-5p↓, 1,   miR-25-5p↑, 1,   miR-27a-3p↑, 1,   miR-339-5p↝, 1,   miR-34a↓, 2,   miR-34a↑, 2,   Myc↓, 5,   MYCN↓, 1,   n-MYC↓, 1,   OCT4↓, 9,   OCT4↑, 1,   other↓, 4,   other↑, 6,   other↝, 10,   PhotoS↑, 2,   SALL4↓, 1,   SETBP1↓, 1,   sonoS↑, 1,   SOX2↓, 7,   SOX4↓, 1,   SOX4↑, 2,   SUV39H↓, 2,   TCF-4↓, 2,   TET3↑, 1,   tumCV?, 1,   tumCV↓, 102,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 5,   cl‑ATF6↑, 1,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 30,   cl‑CHOP/DDIT3↑, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 9,   p‑eIF2α↓, 1,   p‑eIF2α↑, 2,   ER Stress↓, 2,   ER Stress↑, 54,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 21,   GRP94↑, 4,   HSF1↓, 1,   HSP27↓, 7,   HSP27↝, 1,   HSP70/HSPA5↓, 4,   HSP70/HSPA5↑, 1,   HSP70/HSPA5↝, 1,   HSP72↓, 1,   HSP90↓, 11,   HSP90↑, 1,   HSPs↓, 1,   IRE1↑, 6,   PDI↑, 1,   PERK↑, 10,   p‑PERK↑, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 8,   XBP-1↑, 3,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 9,   ATG5↝, 1,   ATG7↑, 2,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 21,   Beclin-1/ATG6↝, 1,   CTSB↓, 2,   CTSD↓, 2,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 4,   LC3A↑, 3,   LC3B↑, 2,   LC3B-II↑, 5,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 7,   LC3s↑, 2,   MitoP↑, 2,   p62↓, 5,   p62↑, 3,   PARK2↑, 2,   SESN2↑, 1,   TumAuto↑, 43,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM↑, 3,   p‑ATM↑, 2,   ATR↑, 1,   p‑BRCA1↑, 1,   DFF45↓, 2,   DFF45↑, 2,   DNA-PK↑, 2,   DNAdam↓, 2,   DNAdam↑, 84,   DNArepair↓, 2,   DNArepair↑, 1,   ERCC1↓, 1,   ERCC4/XPF↓, 1,   hTERT/TERT↓, 14,   Ku70/XRCC6↓, 1,   MGMT↓, 2,   p16↑, 3,   P53?, 1,   P53↓, 3,   P53↑, 123,   P53∅, 1,   p‑P53↓, 1,   p‑P53↑, 5,   p53 Wildtype↓, 1,   PARP↓, 4,   PARP↑, 41,   PARP↝, 1,   p‑PARP↑, 1,   cl‑PARP↓, 3,   cl‑PARP↑, 130,   cl‑PARP∅, 1,   PARP1↑, 2,   cl‑PARP1↑, 3,   PCNA↓, 29,   RAD51↓, 1,   SIRT6↑, 1,   Telomerase↓, 15,   TOP1↓, 2,   TOP2↓, 4,   TP53↑, 1,   UHRF1↓, 1,   γH2AX↑, 11,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 20,   CDK1↑, 4,   p‑CDK1↑, 1,   CDK2↓, 38,   CDK2↑, 4,   p‑CDK2↓, 1,   CDK4↓, 46,   CDK4↑, 3,   p‑CDK4↓, 1,   CDK6↓, 19,   CDK6↑, 2,   CDK8↓, 1,   CHK1↓, 2,   CHK1↑, 1,   p‑CHK1↑, 1,   Chk2↓, 2,   Chk2↑, 1,   ChrCon↑, 2,   Cyc↓, 2,   cycA1/CCNA1↓, 14,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 36,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 81,   cycD1/CCND1↑, 3,   p‑cycD1/CCND1↓, 1,   CycD3↓, 4,   cycE/CCNE↓, 25,   cycE/CCNE↑, 1,   cycE1↓, 1,   E2Fs↓, 3,   Ki-67↓, 16,   mitA↑, 2,   p19↑, 1,   P21?, 1,   P21↓, 4,   P21↑, 84,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 33,   pRB↑, 1,   p‑pRB↓, 2,   RB1↑, 1,   p‑RB1↓, 4,   Securin↓, 1,   TumCCA?, 1,   TumCCA↓, 10,   TumCCA↑, 202,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   ALDH↓, 3,   ALDH1A1↓, 2,   BMP7/OP1↓, 1,   BMPs↑, 1,   CD133↓, 7,   CD24↓, 2,   CD34↓, 1,   CEBPA↑, 1,   cFos↓, 5,   cMYB↓, 1,   CSCs↓, 28,   Diff↓, 1,   Diff↑, 3,   FGF↓, 4,   Gli↓, 1,   Gli1↓, 4,   HH↓, 3,   IGF-1↓, 8,   IGF-2↓, 1,   IGFBP3↑, 3,   JAG1↓, 1,   Jun↓, 1,   p‑Jun↑, 1,   Ki-67↓, 16,   Let-7↑, 3,   mTORC1↓, 5,   p‑mTORC1↓, 1,   Nanog↓, 7,   Nanog↑, 1,   Nestin↓, 3,   NICD↓, 1,   NOTCH↓, 11,   NOTCH1↓, 10,   NOTCH1↑, 1,   NOTCH3↓, 2,   OGFr↑, 2,   PTCH1↓, 1,   SCF↓, 1,   Shh↓, 5,   Smo↓, 3,   STAT1↓, 2,   TAZ↓, 1,   TumCG?, 2,   TumCG↓, 78,   TumCG↑, 3,   TumCP↓, 133,   TumCP↑, 3,   tyrosinase↓, 1,   URGCP/URG4↓, 1,   Wnt?, 1,   Wnt↓, 26,   Wnt/(β-catenin)↓, 6,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 11,   AP-1↑, 1,   BACH1↓, 1,   Ca+2↓, 6,   Ca+2↑, 45,   Ca+2↝, 6,   i-Ca+2↑, 4,   mt-Ca+2↑, 1,   CAFs/TAFs↓, 1,   Cal1↑, 2,   cal2↑, 5,   CCN2/CTGF↓, 1,   Cdc42↑, 1,   COL1↓, 2,   COL3A1↓, 1,   DLC1↑, 3,   E-cadherin↓, 8,   E-cadherin↑, 41,   EM↑, 1,   EMT↓, 53,   EMT↑, 2,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 16,   p‑FAK↓, 2,   Fibronectin↓, 1,   FOSB↑, 1,   GLI2↓, 1,   IQGAP3↓, 1,   ITGA5↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KRAS↓, 1,   LAMs↓, 1,   LEF1↓, 1,   MALAT1↓, 1,   MMP1↓, 5,   MMP13↓, 3,   MMP2↓, 81,   MMP3↓, 5,   MMP7↓, 9,   MMP9↓, 94,   MMP9↑, 1,   MMPs↓, 27,   MUC4↓, 1,   N-cadherin↓, 30,   p‑p44↓, 1,   PAI-1/SERPINE1↑, 1,   PDGF↓, 4,   proline↓, 1,   Rac1↓, 1,   Rho↓, 2,   ROCK1↓, 2,   Slug?, 1,   Slug↓, 11,   Smad1↓, 1,   SMAD2↓, 1,   p‑SMAD2↓, 1,   SMAD3↓, 3,   SMAD3↑, 1,   p‑SMAD3↓, 1,   SMAD4↓, 1,   p‑SMAD4↓, 2,   Snail?, 1,   Snail↓, 26,   TET1↓, 1,   TET1↑, 4,   TGF-β↓, 16,   TGF-β↑, 3,   TIMP1↓, 3,   TIMP1↑, 9,   TIMP2↓, 3,   TIMP2↑, 12,   TIMP3↑, 1,   TRIB3↑, 1,   TSP-1↑, 3,   TumCA↓, 2,   TumCA↑, 1,   TumCI↓, 72,   TumCI↑, 1,   TumCMig↓, 57,   TumMeta↓, 48,   TumMeta↑, 4,   TumPF↓, 2,   Twist↓, 17,   uPA↓, 22,   uPAR↓, 1,   Vim↓, 32,   Zeb1↓, 11,   ZEB2↓, 3,   α-tubulin↓, 1,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 35,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 74,   angioG↑, 1,   CD31/PECAM-1↓, 4,   Endoglin↑, 3,   HIF-1↓, 4,   Hif1a↓, 48,   Hif1a↑, 1,   NO↓, 3,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 84,   VEGF↑, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 16,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4,   BBB∅, 2,   CLDN2↓, 1,   CLDN2↑, 1,   CX43/GJA1↓, 1,   EPR↑, 3,   GLUT1↓, 13,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 201,   MMP↑, 1,   MPT↑, 8,   NHE1↓, 1,   TRPM7↓, 1,   TRPV1↑, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↓, 1,   CD4+↑, 2,   CD44↓, 12,   CD8+↑, 1,   cDC2↓, 2,   p‑cDC2↑, 1,   COX1↓, 1,   COX2/PTGS2↓, 71,   CXCL1↓, 2,   CXCL12↓, 1,   CXCR2↓, 1,   CXCR4↓, 13,   CXCR4↑, 1,   DR4↑, 8,   DR4∅, 1,   FOXP3↓, 1,   FOXP3↑, 1,   HLA-I/II↑, 1,   HMGB1↓, 2,   ICAM-1↓, 4,   IFN-γ↓, 3,   IFN-γ↑, 2,   Igs↓, 1,   IL1↓, 4,   IL10↓, 3,   IL12↓, 2,   IL12↑, 1,   IL17↓, 1,   IL1β↓, 14,   IL2↓, 2,   IL2↑, 2,   IL4↓, 1,   IL6↓, 34,   IL8↓, 6,   Imm↑, 9,   Imm↝, 2,   Inflam↓, 29,   pol-M1↑, 1,   MCP1/CCL2↓, 4,   MCT1↓, 1,   NAF1↓, 1,   NF-kB↓, 122,   NF-kB↑, 4,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 3,   NLRP3↑, 1,   p50↓, 2,   p65↓, 7,   PD-1↓, 1,   PD-L1↓, 3,   PGE2↓, 19,   PSA↓, 7,   RAGE↓, 2,   SOCS-3↓, 1,   T-Cell↑, 2,   T-Cell↝, 1,   Th1 response↑, 2,   Th17↑, 1,   TLR4↓, 3,   TNF-α↓, 30,   TNF-α↑, 5,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRADD↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↑, 1,   IM↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   AR↓, 11,   ER-α36↓, 1,   ER(estro)↓, 1,   PPARα↓, 1,   cl‑PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 3,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   AKR1B10↓, 1,   BioAv↓, 31,   BioAv↑, 36,   BioAv↝, 5,   BioEnh↑, 4,   ChemoSen?, 2,   ChemoSen↓, 3,   ChemoSen↑, 114,   ChemoSen↝, 1,   CompStab↑, 3,   CompStab↝, 2,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1B1↑, 1,   CYP3A4↓, 2,   DDS↑, 1,   Dose?, 5,   Dose↓, 4,   Dose↑, 9,   Dose⇅, 1,   Dose↝, 46,   Dose∅, 7,   eff↓, 77,   eff↑, 69,   eff↝, 8,   eff∅, 1,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 10,   MDR1↓, 4,   MRP1/ABCC1↓, 2,   MRP1/ABCC1↝, 1,   P-gp/ABCB1↓, 13,   P450↓, 4,   RadioS↑, 37,   selectivity?, 1,   selectivity↓, 2,   selectivity↑, 92,   Synergy?, 1,   Synergy↑, 76,   TET2↓, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 2,   ALAT↑, 1,   ALAT↝, 1,   ALP↝, 1,   AR↓, 11,   AST↓, 2,   AST↑, 1,   AST↝, 1,   BRAF↝, 1,   p‑BRCA1↑, 1,   CEA↓, 1,   CRP↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 1,   HER2/EBBR2↓, 14,   hTERT/TERT↓, 14,   IL6↓, 34,   KRAS↓, 1,   LDH↓, 5,   LDH↑, 5,   LDH↝, 2,   Myc↓, 5,   PD-L1↓, 3,   PSA↓, 7,   RAGE↓, 2,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 46,   antiD↑, 1,   antiNeop↑, 1,   AntiTum↑, 24,   cachexia↓, 2,   cardioP↑, 5,   CardioT↑, 1,   chemoP↑, 24,   chemoPv↑, 18,   chemoPv⇅, 1,   ChemoSideEff↓, 5,   cognitive?, 1,   hepatoP↓, 1,   hepatoP↑, 7,   neuroP↑, 2,   NP/CIPN↓, 1,   OS↑, 8,   Pain↓, 2,   PFS↓, 1,   Pin1↓, 2,   QoL↑, 4,   QoL∅, 1,   radioP↑, 6,   RenoP↑, 9,   Risk↓, 10,   Strength↑, 1,   toxicity↓, 12,   toxicity↑, 4,   toxicity↝, 4,   toxicity∅, 1,   TumNum↓, 2,   TumVol↓, 26,   TumVol↑, 1,   TumW↓, 15,   Weight↑, 2,   Weight∅, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 1,   Bacteria↓, 2,   GutMicro↑, 2,   GutMicro↝, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 7,  
Total Targets: 1035

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 5,   antiOx↑, 80,   ARE↑, 1,   Catalase↓, 1,   Catalase↑, 39,   Fenton↓, 1,   GPx↑, 31,   GSH↑, 39,   GSR↓, 1,   GSR↑, 4,   GSTs↓, 2,   GSTs↑, 11,   H2O2↓, 2,   HDL↑, 2,   HO-1↓, 2,   HO-1↑, 16,   Keap1↓, 2,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 29,   MDA↓, 29,   MPO↓, 4,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 3,   NRF2↓, 1,   NRF2↑, 36,   Prx↑, 1,   RNS↓, 4,   ROS↓, 96,   ROS↑, 4,   ROS⇅, 1,   ROS∅, 1,   mt-ROS?, 1,   SOD↓, 2,   SOD↑, 47,   SOD1↑, 1,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 3,   Trx↑, 1,   uricA↓, 1,   VitC↑, 1,   VitE↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 2,   IronCh↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

DRP1/DNM1L↓, 1,   FIS1↓, 1,   Insulin↑, 1,   MFN2↑, 1,   mitResp↑, 1,   mtDam↓, 2,   PGC-1α↑, 2,   PGC-1α↝, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 1,   adiP↑, 1,   ALAT↓, 12,   AMPK↓, 1,   AMPK↑, 5,   ATP↓, 2,   ATP↑, 7,   cAMP↑, 2,   DGAT1↓, 1,   FASN↓, 1,   glucose↓, 3,   glucose↝, 1,   GlucoseCon↑, 1,   GSK‐3β↓, 5,   H2S↑, 2,   HMG-CoA↓, 1,   LDHA↑, 1,   LDL↓, 3,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 3,   NADPH↑, 2,   PLA2↓, 1,   SIRT1↑, 7,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   APAF1↓, 2,   Apoptosis↓, 15,   Apoptosis↑, 1,   Apoptosis∅, 1,   ASK1↓, 1,   BAX↓, 18,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 3,   Bax:Bcl2↝, 1,   Bcl-2↓, 3,   Bcl-2↑, 12,   Bcl-xL↑, 1,   Casp↓, 1,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 35,   Casp3↑, 3,   Casp3∅, 1,   cl‑Casp3↓, 3,   cl‑Casp3↑, 1,   Casp6↓, 1,   Casp8↓, 3,   Casp8↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 29,   Casp9↑, 4,   Casp9∅, 1,   cl‑Casp9↓, 4,   cl‑Casp9↑, 1,   Cyt‑c↓, 11,   Cyt‑c∅, 1,   Fas↓, 2,   Fas↑, 2,   FasL↓, 1,   GSDMD↓, 1,   iNOS↓, 17,   iNOS↑, 1,   MLKL↓, 1,   necrosis↓, 1,   p38↓, 2,   p‑p38↓, 1,   Pyro↓, 1,   TUNEL↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 6,   p‑Akt↓, 1,   p‑Akt↑, 1,   Akt2↓, 1,   CaMKII ↓, 1,   CREB↑, 2,   ERK↓, 5,   ERK↑, 3,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IKKα↓, 1,   IKKα↑, 1,   IκB?, 1,   JAK↓, 1,   JAK2↑, 1,   JNK↓, 5,   p‑JNK↓, 2,   MAPK↓, 8,   mTOR↓, 1,   mTOR↑, 4,   p‑mTOR↓, 1,   PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 5,   PI3K↑, 5,   PKCδ↓, 1,   PKCδ↑, 1,   RIP1↓, 1,   STAT↓, 1,   STAT3↓, 2,   STAT3↑, 3,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   ATF4↓, 1,   cJun↓, 1,   p‑cMyc↑, 1,   HDAC↓, 2,   HDAC2↓, 1,   HDAC3↓, 1,   HOTAIR↑, 1,   other↓, 2,   other↑, 5,   other↝, 5,   RUNX2↑, 1,   tumCV↓, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 1,   CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   GRP78/BiP↑, 2,   GRP94↑, 1,   HSP27↑, 1,   HSP70/HSPA5↑, 1,   HSPs↓, 1,   HSPs↑, 1,   IRE1↓, 1,   PERK↓, 1,   UPR↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 4,   Beclin-1/ATG6↑, 2,   LC3II↓, 1,   LC3II↑, 2,   p62↓, 1,   p62↑, 2,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 5,   p16↓, 1,   P53↓, 5,   P53↑, 2,   PARP∅, 1,   cl‑PARP↓, 1,   cl‑PARP↑, 2,   PARP1↓, 1,   p‑γH2AX↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   cycA1/CCNA1↓, 1,   cycE/CCNE↑, 1,   GADD34↓, 1,   Ki-67↓, 1,   P21↓, 3,   P21↑, 2,   TumCCA↑, 3,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP2↑, 1,   Diff↝, 1,   Ki-67↓, 1,   neuroG↑, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 1,   Ca+2↓, 1,   Ca+2↑, 1,   COL1↓, 2,   COL1↑, 1,   E-cadherin↓, 1,   E-cadherin↑, 1,   EMT↓, 1,   MLC2/MYL9↝, 1,   MMP13↓, 2,   MMP9↓, 1,   p‑Rac1↓, 1,   Rho↓, 1,   ROCK1↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↑, 1,   p‑T-cadherin↓, 1,   TGF-β↓, 1,   TregCell↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   Vim↓, 1,   Zeb1↓, 1,   α-SMA↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   eNOS↑, 1,   Hif1a↓, 4,   Hif1a↑, 1,   NO↓, 11,   NO↑, 1,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 12,   GastroP↑, 3,   GLUT2↑, 1,   GLUT4↑, 1,   IBI↑, 1,   MMP↓, 3,   MMP↑, 10,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPC1↓, 1,   ZO-1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

AIF1/Iba-1↓, 1,   CD19↑, 1,   CD25+↑, 1,   CD4+↑, 3,   CD40↓, 1,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 26,   COX2/PTGS2↑, 1,   CXCR4↓, 1,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 2,   IL1↓, 1,   IL10↓, 7,   IL10↑, 4,   IL17↓, 2,   IL18↓, 2,   IL1β↓, 25,   IL2↓, 3,   IL33↓, 1,   IL4↓, 2,   IL4↑, 1,   IL5↓, 1,   IL6↓, 34,   IL6↑, 1,   IL8↓, 4,   Imm↓, 1,   Imm↑, 5,   INF-γ↓, 2,   Inflam↓, 92,   Inflam↑, 1,   IP-10/CXCL-10↓, 1,   LPS↓, 1,   M2 MC↑, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 2,   MyD88↓, 1,   NeuroI↓, 2,   NF-kB↓, 32,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 3,   PGE2↓, 14,   RANTES↓, 1,   TLR4↓, 6,   TNF-α↓, 46,   Treg lymp↝, 1,   TRIF↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 3,   Ach↑, 1,   AChE↓, 12,   BChE↓, 4,   BDNF↓, 1,   BDNF↑, 9,   ChAT↑, 2,   DA↑, 1,   MAOA↓, 2,   NGF↑, 2,   PSD95↑, 1,   SNAP25↑, 1,   TPH1↓, 1,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   Aβ↓, 13,   Aβ42↓, 3,   BACE/β-secretase↓, 6,   IDE↑, 1,   tau↓, 3,   p‑tau↓, 2,   XO↝, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

BNP↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 5,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 28,   BioAv↑, 29,   BioAv⇅, 1,   BioAv↝, 13,   BioEnh↑, 2,   CYP2D6↓, 1,   CYP2E1↓, 2,   Dose↓, 1,   Dose↑, 1,   Dose⇅, 1,   Dose↝, 8,   eff↓, 2,   eff↑, 9,   eff↝, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 2,   Half-Life↝, 9,   P-gp/ABCB1↓, 2,   P450↓, 2,   P450↝, 1,   selectivity↑, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 12,   ALB↝, 1,   ALP↓, 5,   AST↓, 11,   BG↓, 1,   BloodF↑, 2,   BP↓, 5,   BUN?, 1,   BUN↓, 2,   CEA↓, 1,   creat↓, 8,   CRP↓, 3,   hs-CRP↓, 1,   IL6↓, 34,   IL6↑, 1,   LDH↓, 6,   NOS2↓, 1,   SpO2↑, 1,   Urea↓, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 1,   antiAll↑, 14,   AntiArt↑, 4,   AntiCan↑, 15,   antiCG↑, 1,   AntiDiabetic↑, 20,   antiNeop↑, 1,   antiPs↑, 3,   AntiTum↓, 2,   AntiTum↑, 5,   cardioP?, 1,   cardioP↑, 33,   chemoP↑, 7,   chemoPv↑, 1,   cognitive↑, 16,   diuretic↑, 3,   hepatoP↑, 30,   Learn↑, 1,   memory↑, 12,   motorD↑, 4,   Mucositis↓, 2,   neuroP↓, 1,   neuroP↑, 53,   Obesity↓, 4,   OS↑, 1,   Pain↓, 2,   radioP↑, 3,   RenoP↑, 8,   Stroke↓, 4,   toxicity?, 1,   toxicity↓, 36,   toxicity↑, 4,   toxicity↝, 7,   toxicity∅, 8,   Weight↑, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 14,   AntiFungal↓, 1,   AntiFungal↑, 3,   AntiP↑, 2,   AntiViral↑, 8,   Bacteria↓, 15,   Diar↓, 2,   GutMicro↑, 10,   Inf↓, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 4,  
Total Targets: 431

Scientific Paper Hit Count for: Casp9, Caspase-9
21 Quercetin
18 Silver-NanoParticles
18 Baicalein
17 Luteolin
16 Curcumin
16 Thymoquinone
15 Emodin
14 Fisetin
13 Kaempferol
12 Sulforaphane (mainly Broccoli)
11 Apigenin (mainly Parsley)
11 Magnolol
9 Allicin (mainly Garlic)
9 Berberine
9 Betulinic acid
9 Chrysin
9 Morin
8 Cisplatin
8 Honokiol
8 Silymarin (Milk Thistle) silibinin
7 Artemisinin
7 Alpha-Lipoic-Acid
7 EGCG (Epigallocatechin Gallate)
7 Gambogic Acid
6 Allyl isothiocyanate
6 Phenethyl isothiocyanate
6 Citric Acid
6 D-limonene
6 Eugenol
6 Garcinol
6 Graviola
5 Benzyl isothiocyanate
5 Ginkgetin
5 Ivermectin
5 Matrine
5 Shikonin
4 Cynara scolymus/Globe Artichoke/Artichoke Extract
4 Ashwagandha(Withaferin A)
4 Bromelain
4 Boron
4 Capsaicin
4 Carvacrol
4 chaetocin
4 Photodynamic Therapy
4 Radiotherapy/Radiation
4 Formononetin
4 Fucoidan
4 Juglone
4 Licochalcone A
4 Lycopene
4 Magnetic Fields
4 Plumbagin
4 Resveratrol
3 5-fluorouracil
3 Berbamine
3 Boswellia (frankincense)
3 α-Bisabolol / Chamomile oil
3 Carnosic acid
3 Chlorogenic acid
3 Dandelion Root
3 Evodiamine
3 Ferulic acid
3 Gallic acid
3 Geraniol
3 Gossypol/AT-101
3 HydroxyTyrosol
3 Hyperoside
3 Isoliquiritigenin
3 isoorientin
3 Vitexin
3 Licorice
3 Mushroom Lion’s Mane, Hericium erinaceus
3 Propolis -bee glue
3 Piperlongumine
3 Selenium NanoParticles
3 Aflavin-3,3′-digallate
2 Astragalus
2 Andrographis
2 Anethole/trans-Anethole
2 Aloe anthraquinones
2 Beta-Caryophyllene
2 Brucea javanica
2 Bullatacin
2 Thymol-Thymus vulgaris
2 Celastrol
2 Centella asiatica / Gotu kola → asiaticoside
2 Cichoric acid / Chicoric acid
2 Carvone
2 Polyphenols
2 Deguelin
2 Docetaxel
2 Echinacea
2 Electrical Pulses
2 Paclitaxel/Taxol
2 Hydrogen Gas
2 Chemotherapy
2 Hibiscus sabdariffa
2 Rutin
2 Isobavachalcone
2 phytic acid, Inositol hexakisphosphate
2 Isorhamnetin
2 isoquercitrin
2 lambertianic acid
2 low dose naltrexone
2 Linalool
2 methylseleninic acid
2 Mangiferin
2 doxorubicin
2 Mistletoe/Viscum album Extracts
2 Nimbolide
2 Oleuropein
2 Phycocyanin
2 Rosmarinic acid
2 salinomycin
2 Selenium
2 chitosan
2 Selenite (Sodium)
2 Ursolic acid
1 1,8-Cineole
1 entinostat
1 Camptothecin
1 Resiquimod
1 Gemcitabine (Gemzar)
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Fennel Oil/Foeniculum vulgare
1 Metformin
1 2-DeoxyGlucose
1 almonertinib
1 epirubicin
1 Biochanin A
1 Bufalin/Huachansu
1 brusatol
1 borneol
1 Caffeic acid
1 Sorafenib (brand name Nexavar)
1 Celecoxib
1 Chlorophyllin
1 Cinnamon
1 immunotherapy
1 Crocetin
1 Cucurbitacin
1 Cynaropicrin
1 Diclofenac
1 diet Methionine-Restricted Diet
1 Ellagic acid
1 Ginkgo biloba-EGb 761
1 Geldanamycin
1 Radicicol/monorden
1 Flaxseed/Linseed
1 olaparib/LYNPARZA
1 Ginkgolic acids
1 Ginkgo biloba
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 Hydroxycinnamic-acid
1 Helleborus niger extracts – Christmas Rose
1 Baicalin
1 Indole-3-carbinol
1 carboplatin
1 Isovitexin
1 L-Theanine
1 Lactobacillus
1 tumor necrosis factor-related apoptosis-inducing ligand
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 Magnetic Field Rotating
1 Moringin
1 Melatonin
1 Moringa oleifera
1 Methylsulfonylmethane
1 Marjoram (Origanum majorana)
1 Patchouli Oil (Pogostemon cablin)
1 sericin
1 Propyl gallate
1 topotecan
1 Piperine
1 Rauwolfia serpentina/Indian Snakeroot
1 buckwheat sprouts
1 Sanguinarine
1 α-Santalol/Sandalwood oil
1 polyethylene glycol
1 Auranofin
1 Spirulina(Arthrospira/Limnospira)
1 Terpinen-4-ol / Tea Tree Oil
1 Urolithin
1 Vitamin C (Ascorbic Acid)
1 Vitamin D3
1 Vitamin K2
1 VitK3,menadione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:45  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page